NC
PPH icon

NewSquare Capital’s VanEck Pharmaceutical ETF PPH Stock Holding History

NewSquare Capital’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-97
Closed -$7.53K – 923
2023
Q1 		$7.53K Hold
97
– – ﹤0.01% 383
2022
Q4 		$7.54K Hold
97
– – ﹤0.01% 321
2022
Q3 		$7K Hold
97
– – ﹤0.01% 279
2022
Q2 		$7K Hold
97
– – ﹤0.01% 265
2022
Q1 		$8K Hold
97
– – ﹤0.01% 274
2021
Q4 		$7K Hold
97
– – ﹤0.01% 305
2021
Q3 		$7K Buy
+97
New +$7.24K ﹤0.01% 298

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
AT
Avalon Trust Santa Fe, New Mexico $1.45B AUM 35.31% 1-Year Est. Return
PCIA
Prime Capital Investment Advisors Overland Park, Kansas $8.65B AUM 19.52% 1-Year Est. Return
MIM
Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return
VAS
Valicenti Advisory Services Elmira, New York $530M AUM 46.5% 1-Year Est. Return
AF
Alerus Financial Grand Forks, North Dakota $2.02B AUM 26.03% 1-Year Est. Return

NewSquare Capital's PPH Position: Q2 2023 in Review

NewSquare Capital sold out of VanEck Pharmaceutical ETF (PPH) in Q2 2023, closing a stake of 97 shares — an estimated $7.53K sold.

NewSquare Capital first reported a position in PPH in Q3 2021 and held it in 7 quarters. The position peaked at $8K in Q1 2022. 102 funds tracked by Wall St. Rank hold PPH as of Q2 2023.

  • NewSquare Capital reported no remaining VanEck Pharmaceutical ETF position as of Q2 2023 after selling out during the quarter.
  • NewSquare Capital sold 97 VanEck Pharmaceutical ETF shares in Q2 2023, an estimated $7.53K.
  • NewSquare Capital first reported a position in VanEck Pharmaceutical ETF in Q3 2021 and held it in 7 quarters.
  • NewSquare Capital's VanEck Pharmaceutical ETF position peaked at $8K in Q1 2022.
  • 102 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2023.

Based on NewSquare Capital's 13F filing for Q2 2023, filed 3 Aug 2023.